{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:37:23Z","timestamp":1776508643755,"version":"3.51.2"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Gastroenterol Rep"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1007\/s11894-006-0058-9","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T02:41:34Z","timestamp":1180060894000},"page":"7-13","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices"],"prefix":"10.1007","volume":"8","author":[{"given":"Don C.","family":"Rockey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"58_CR1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/j.1572-0241.2003.07294.x","volume":"98","author":"N Chalasani","year":"2003","unstructured":"Chalasani N, Kahi C, Francois F, et al.: Improved patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003, 98:653\u2013659. Demonstrates that outcomes appear to be improving-implying that implementation of newer therapeutics and intensive care has improved patient care.","journal-title":"Am J Gastroenterol"},{"key":"58_CR2","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/j.1572-0241.2003.07517.x","volume":"98","author":"ME Leerdam van","year":"2003","unstructured":"van Leerdam ME, Vreeburg EM, Rauws EA, et al.: Acute upper GI bleeding: did anything change? Time trend analysis of incidence and outcome of acute upper GI bleeding between 1993\/1994 and 2000. Am J Gastroenterol 2003, 98:1494\u20131499.","journal-title":"Am J Gastroenterol"},{"key":"58_CR3","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1053\/jhep.2003.50385","volume":"38","author":"G D'Amico","year":"2003","unstructured":"D'Amico G, De Franchis R: Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003, 38:599\u2013612.","journal-title":"Hepatology"},{"key":"58_CR4","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50044","volume":"37","author":"DC Rockey","year":"2003","unstructured":"Rockey DC: Vascular mediators in the injured liver. Hepatology 2003, 37:4\u201312. Includes a concise overview of the pathophysiologic basis of intrahepatic portal hypertension.","journal-title":"Hepatology"},{"key":"58_CR5","first-page":"1297","volume":"69","author":"A Viallet","year":"1975","unstructured":"Viallet A, Marleau D, Huet M, et al.: Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology 1975, 69:1297\u20131300.","journal-title":"Gastroenterology"},{"key":"58_CR6","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/0016-5085(80)90905-1","volume":"79","author":"D Lebrec","year":"1980","unstructured":"Lebrec D, De Fleury P, Rueff B, et al.: Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology 1980, 79:1139\u20131144. Emphasizes that the worse the liver disease, the larger the varices, and the more likely they are to bleed.","journal-title":"Gastroenterology"},{"key":"58_CR7","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/hep.1840050313","volume":"5","author":"G Garcia-Tsao","year":"1985","unstructured":"Garcia-Tsao G, Groszmann RJ, Fisher RL, et al.: Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology 1985, 5:419\u2013424. The seminal observation that esophageal varices bleed only after HVPG exceeds 12 mm Hg.","journal-title":"Hepatology"},{"key":"58_CR8","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0016-5085(90)90652-H","volume":"99","author":"P Cales","year":"1990","unstructured":"Cales P, Pascal JP: Gastroesophageal endoscopic features in cirrhosis: comparison of intracenter and intercenter observer variability. Gastroenterology 1990, 99:1189.","journal-title":"Gastroenterology"},{"key":"58_CR9","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1046\/j.1440-1746.1999.01949.x","volume":"14","author":"FH Ng","year":"1999","unstructured":"Ng FH, Wong SY, Loo CK, et al.: Prediction of oesopha gogastric varices in patients with liver cirrhosis. J Gastroenterol Hepatol 1999, 14:785\u2013790.","journal-title":"J Gastroenterol Hepatol"},{"key":"58_CR10","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1111\/j.1572-0241.1999.1539_a.x","volume":"94","author":"N Chalasani","year":"1999","unstructured":"Chalasani N, Imperiale TF, Ismail A, et al.: Predictors of large esophageal varices in patients with cirrhosis. Am J Gastroenterol 1999, 94:3285\u2013291. Low platelets and splenomegaly appear to be the most useful predictors of the presence of large varices.","journal-title":"Am J Gastroenterol"},{"key":"58_CR11","doi-asserted-by":"crossref","unstructured":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices: a prospective multicenter study. The North Italian Endoscopic Club for the Study and Treatment of Esophageal Varices. N Engl J Med 1988, 319:983\u2013989.","DOI":"10.1056\/NEJM198810133191505"},{"key":"58_CR12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0016-5107(81)73224-3","volume":"27","author":"K Beppu","year":"1981","unstructured":"Beppu K, Inokuchi K, Koyanagi N, et al.: Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981, 27:213\u2013218.","journal-title":"Gastrointest Endosc"},{"key":"58_CR13","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/0016-5085(91)70021-O","volume":"100","author":"G Kleber","year":"1991","unstructured":"Kleber G, Sauerbruch T, Ansari H, Paumgartner G: Prediction of variceal hemorrhage in cirrhosis: a prospective follow-up study. Gastroenterology 1991, 100:1332\u20131337.","journal-title":"Gastroenterology"},{"key":"58_CR14","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1136\/gut.30.12.1757","volume":"30","author":"SK Sarin","year":"1989","unstructured":"Sarin SK, Sundaram KR, Ahuja RK: Predictors of variceal bleeding: an analysis of clinical, endoscopic, and haemodynamic variables, with special reference to intravariceal pressure. Gut 1989, 30:1757\u20131764.","journal-title":"Gut"},{"key":"58_CR15","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMra003007","volume":"345","author":"AI Sharara","year":"2001","unstructured":"Sharara AI, Rockey DC: Gastroesophageal variceal hemorrhage. N Engl J Med 2001, 345:669\u2013681.","journal-title":"N Engl J Med"},{"key":"58_CR16","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0016-5085(77)80136-4","volume":"72","author":"TD Boyer","year":"1977","unstructured":"Boyer TD, Triger DR, Horisawa M, et al.: Direct transhepatic measurement of portal vein pressure using a thin needle. Comparison with wedged hepatic vein pressure. Gastroenterology 1977, 72:584\u2013589.","journal-title":"Gastroenterology"},{"key":"58_CR17","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0016-5085(92)90185-2","volume":"102","author":"C Merkel","year":"1992","unstructured":"Merkel C, Bolognesi M, Bellon S, et al.: Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology 1992, 102:973\u2013979.","journal-title":"Gastroenterology"},{"key":"58_CR18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa003223","volume":"345","author":"C Villanueva","year":"2001","unstructured":"Villanueva C, Minana J, Ortiz J, et al.: Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001, 345:647\u2013655. Important study that additionally demonstrated that those patients with a hemodynamic response to a-blocker therapy have an extremely low risk of recurrent bleeding, emphasizing that physiologic assessment of portal pressure is critical.","journal-title":"N Engl J Med"},{"key":"58_CR19","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1053\/jhep.2000.19322","volume":"32","author":"C Merkel","year":"2000","unstructured":"Merkel C, Bolognesi M, Sacerdoti D, et al.: The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000, 32:930\u2013934.","journal-title":"Hepatology"},{"key":"58_CR20","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/S0016-5085(99)70455-5","volume":"117","author":"E Moitinho","year":"1999","unstructured":"Moitinho E, Escorsell A, Bandi JC, et al.: Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology 1999, 117:626\u2013631.","journal-title":"Gastroenterology"},{"key":"58_CR21","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/hep.20061","volume":"39","author":"U Thalheimer","year":"2004","unstructured":"Thalheimer U, Mela M, Patch D, Burroughs AK: Targeting portal pressure measurements: a critical reappraisal. Hepatology 2004, 39:286\u2013290.","journal-title":"Hepatology"},{"key":"58_CR22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hep.20037","volume":"39","author":"TD Boyer","year":"2004","unstructured":"Boyer TD: Changing clinical practice with measurements of portal pressure. Hepatology 2004, 39:283\u2013285.","journal-title":"Hepatology"},{"key":"58_CR23","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.49.5.682","volume":"49","author":"PA McCormick","year":"2001","unstructured":"McCormick PA, O'Keefe C: Improving prognosis following a first variceal haemorrhage over four decades. Gut 2001, 49:682\u2013685.","journal-title":"Gut"},{"key":"58_CR24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1053\/jhep.2001.21410","volume":"33","author":"F Schepis","year":"2001","unstructured":"Schepis F, Camma C, Niceforo D, et al.: Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology 2001, 33:333\u2013338.","journal-title":"Hepatology"},{"key":"58_CR25","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/hep.1840220145","volume":"22","author":"G D'Amico","year":"1995","unstructured":"D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: a meta-analytic review. Hepatology 1995, 22:332\u2013354.","journal-title":"Hepatology"},{"key":"58_CR26","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/S0140-6736(95)91740-3","volume":"346","author":"F Feu","year":"1995","unstructured":"Feu F, Garcia-Pagan JC, Bosch J, et al.: Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet 1995, 346:1056\u20131059.","journal-title":"Lancet"},{"key":"58_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/hep.1840020502","volume":"2","author":"D Lebrec","year":"1982","unstructured":"Lebrec D, Hillon P, Munoz C, et al.: The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study. Hepatology 1982, 2:523\u2013527.","journal-title":"Hepatology"},{"key":"58_CR28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0140-6736(90)91668-Z","volume":"336","author":"PC Hayes","year":"1990","unstructured":"Hayes PC, Davis JM, Lewis JA, Bouchier IA: Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 1990, 336:153\u2013156.","journal-title":"Lancet"},{"key":"58_CR29","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1055\/s-2007-1007133","volume":"19","author":"G D'Amico","year":"1999","unstructured":"D'Amico G, Pagliaro L, Bosch J: Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999, 19:475\u2013505.","journal-title":"Semin Liver Dis"},{"key":"58_CR30","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1046\/j.1365-2036.2000.00778.x","volume":"14","author":"J Vlachogiannakos","year":"2000","unstructured":"Vlachogiannakos J, Goulis J, Patch D, Burroughs AK: Review article: primary prophylaxis for portal hypertensive bleeding in cirrhosis. Aliment Pharmacol Ther 2000, 14:851\u2013860.","journal-title":"Aliment Pharmacol Ther"},{"key":"58_CR31","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/gast.1997.v112.pm9024301","volume":"112","author":"JC Teran","year":"1997","unstructured":"Teran JC, Imperiale TF, Mullen KD, et al.: Primary prophylaxis of variceal bleeding in cirrhosis: a costeffectiveness analysis. Gastroenterology 1997, 112:473\u2013482.","journal-title":"Gastroenterology"},{"key":"58_CR32","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-123-4-199508150-00007","volume":"123","author":"L Laine","year":"1995","unstructured":"Laine L, Cook D: Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding. A meta-analysis. Ann Intern Med 1995, 123:280\u2013287.","journal-title":"Ann Intern Med"},{"key":"58_CR33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1056\/NEJM199904013401302","volume":"340","author":"SK Sarin","year":"1999","unstructured":"Sarin SK, Lamba GS, Kumar M, et al.: Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999, 340:988\u2013993.","journal-title":"N Engl J Med"},{"key":"58_CR34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1046\/j.1440-1746.1999.01800.x","volume":"14","author":"BK De","year":"1999","unstructured":"De BK, Ghoshal UC, Das T, et al.: Endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleed: preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 1999, 14:220\u2013224.","journal-title":"J Gastroenterol Hepatol"},{"key":"58_CR35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1053\/gast.2002.35385","volume":"123","author":"HF Lui","year":"2002","unstructured":"Lui HF, Stanley AJ, Forrest EH, et al.: Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 2002, 123:735\u2013744.","journal-title":"Gastroenterology"},{"key":"58_CR36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0016-5107(03)02819-0","volume":"59","author":"GH Lo","year":"2004","unstructured":"Lo GH, Chen WC, Chen MH, et al.: Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004, 59:333\u2013338. The most recent in a series of studies comparing endoscopic band ligation and nadolol for primary prevention of esophageal variceal hemorrhage. This study demonstrated no difference in the two approaches.","journal-title":"Gastrointest Endosc"},{"key":"58_CR37","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1053\/gast.1997.v113.pm9352866","volume":"113","author":"M Angelico","year":"1997","unstructured":"Angelico M, Carli L, Piat C, et al.: Effects of isosorbide-5-mononitrate compared with propranolol on first bleeding and long-term survival in cirrhosis. Gastroenterology 1997, 113:1632\u20139.","journal-title":"Gastroenterology"},{"key":"58_CR38","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S1590-8658(01)80707-6","volume":"33","author":"M Angelico","year":"2001","unstructured":"Angelico M, Lionetti R: Long-acting nitrates in portal hypertension: to be or not to be? Dig Liver Dis 2001, 33:205\u2013211.","journal-title":"Dig Liver Dis"},{"key":"58_CR39","doi-asserted-by":"crossref","first-page":"869","DOI":"10.7326\/0003-4819-114-10-869","volume":"114","author":"JC Garcia-Pagan","year":"1991","unstructured":"Garcia-Pagan JC, Feu F, Bosch J, Rodes J: Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: a randomized controlled study. Ann Intern Med 1991, 114:869\u2013873.","journal-title":"Ann Intern Med"},{"key":"58_CR40","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/hep.510310210","volume":"31","author":"C Merkel","year":"2000","unstructured":"Merkel C, Marin R, Sacerdoti D, et al.: Long-term results of a clinical trial of nadolol with or without isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Hepatology 2000, 31:324\u2013329.","journal-title":"Hepatology"},{"key":"58_CR41","first-page":"399A","volume":"34","author":"R Bataller","year":"2001","unstructured":"Bataller R, Gines P, Lora J, et al.: Evidence for a local renin-angiotensin system in human liver: Expression in activated hepatic stellate cells. Hepatology 2001, 34:399A.","journal-title":"Hepatology"},{"key":"58_CR42","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.510290203","volume":"29","author":"AW Schneider","year":"1999","unstructured":"Schneider AW, Kalk JF, Klein CP: Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 1999, 29:334\u2013339.","journal-title":"Hepatology"},{"key":"58_CR43","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1053\/gast.2001.26288","volume":"121","author":"J Gonzalez-Abraldes","year":"2001","unstructured":"Gonzalez-Abraldes J, Albillos A, Banares R, et al.: Randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology 2001, 121:382\u2013388.","journal-title":"Gastroenterology"},{"key":"58_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0016-5085(75)80001-1","volume":"68","author":"HO Conn","year":"1975","unstructured":"Conn HO, Ramsby GR, Storer EH, et al.: Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology 1975, 68:211\u2013221.","journal-title":"Gastroenterology"},{"key":"58_CR45","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1002\/hep.1840100612","volume":"10","author":"J Bosch","year":"1989","unstructured":"Bosch J, Groszmann RJ, Garcia-Pagan JC, et al.: Association of transdermal nitroglycerin to vasopressin infusion in the treatment of variceal hemorrhage: a placebo-controlled clinical trial. Hepatology 1989, 10:962\u2013968.","journal-title":"Hepatology"},{"key":"58_CR46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(95)92708-5","volume":"346","author":"S Levacher","year":"1995","unstructured":"Levacher S, Letoumelin P, Pateron D, et al.: Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients. Lancet 1995, 346:865\u2013868.","journal-title":"Lancet"},{"key":"58_CR47","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-2036.2003.01356.x","volume":"17","author":"GN Ioannou","year":"2003","unstructured":"Ioannou GN, Doust J, Rockey DC: Systematic review: terlipressin in acute oesophageal variceal haemorrhage. Aliment Pharmacol Ther 2003, 17:53\u201364. Demonstrated that terlipressin is the only pharmacologic agent that improves mortality when used in the setting of acute variceal bleeding.","journal-title":"Aliment Pharmacol Ther"},{"key":"58_CR48","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1053\/gast.1996.v111.pm8898643","volume":"111","author":"F Feu","year":"1996","unstructured":"Feu F, Ruiz del Arbol L, Banares R, et al.: Double-blind randomized controlled trial comparing terlipressin and somatostatin for acute variceal hemorrhage. Variceal Bleeding Study Group. Gastroenterology 1996, 111:1291\u20131299.","journal-title":"Gastroenterology"},{"key":"58_CR49","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1053\/gast.2001.22451","volume":"120","author":"DA Corley","year":"2001","unstructured":"Corley DA, Cello JP, Adkisson W, et al.: Octreotide for acute esophageal variceal bleeding: a meta-analysis. Gastroenterology 2001, 120:946\u2013954.","journal-title":"Gastroenterology"},{"key":"58_CR50","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM199508313330904","volume":"333","author":"I Besson","year":"1995","unstructured":"Besson I, Ingrand P, Person B, et al.: Sclerotherapy with or without octreotide for acute variceal bleeding. N Engl J Med 1995, 333:555\u2013560.","journal-title":"N Engl J Med"},{"key":"58_CR51","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/S0140-6736(95)92840-5","volume":"346","author":"JJ Sung","year":"1995","unstructured":"Sung JJ, Chung SC, Yung MY, et al.: Prospective randomised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic ligation. Lancet 1995, 346:1666\u20131669.","journal-title":"Lancet"},{"key":"58_CR52","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1053\/jhep.2002.31354","volume":"35","author":"R Banares","year":"2002","unstructured":"Banares R, Albillos A, Rincon D, et al.: Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology 2002, 35:609\u2013615.","journal-title":"Hepatology"},{"key":"58_CR53","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0889-8553(21)00179-5","volume":"21","author":"R Franchis de","year":"1992","unstructured":"de Franchis R, Primignani M: Why do varices bleed? Gastroenterol Clin North Am 1992, 21:85\u2013101.","journal-title":"Gastroenterol Clin North Am"},{"key":"58_CR54","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.510280339","volume":"28","author":"ND Grace","year":"1998","unstructured":"Grace ND, Groszmann RJ, Garcia-Tsao G, et al.: Portal hypertension and variceal bleeding: an AASLD single topic symposium. Hepatology 1998, 28:868\u2013880.","journal-title":"Hepatology"},{"key":"58_CR55","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1590-8658(01)80036-0","volume":"33","author":"R Franchis de","year":"2001","unstructured":"de Franchis R, Dellera A, Fazzini L, et al.: Evaluation and follow-up of patients with portal hypertension and oesophageal varices: how and when. Dig Liver Dis 2001, 33:643\u2013646.","journal-title":"Dig Liver Dis"},{"issue":"Suppl 3","key":"58_CR56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2036.2004.02108.x","volume":"20","author":"R Franchis de","year":"2004","unstructured":"de Franchis R: Review article: definition and diagnosis in portal hypertension-continued problems with the Baveno consensus? Aliment Pharmacol Ther 2004, 20(Suppl 3):2\u20136, discussion 7.","journal-title":"Aliment Pharmacol Ther"},{"key":"58_CR57","doi-asserted-by":"crossref","first-page":"725A","DOI":"10.1016\/S0168-8278(04)00079-0","volume":"40","author":"JM Henderson","year":"2004","unstructured":"Henderson JM, Boyer TD, Kutner MH, et al.: DSRS vs. TIPS for refractory variceal bleeding: a prospective randomized controlled trial. Hepatology 2004, 40:725A.","journal-title":"Hepatology"},{"key":"58_CR58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/hep.510250112","volume":"25","author":"B Bernard","year":"1997","unstructured":"Bernard B, Lebrec D, Mathurin P, et al.: Beta-adrenergic antagonists in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis. Hepatology 1997, 25:63\u201370.","journal-title":"Hepatology"},{"key":"58_CR59","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1016\/0016-5085(92)91740-U","volume":"102","author":"JP Vinel","year":"1992","unstructured":"Vinel JP, Lamouliatte H, Cales P, et al.: Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration. Gastroenterology 1992, 102:1760\u20133.","journal-title":"Gastroenterology"},{"key":"58_CR60","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/jhep.2000.16236","volume":"32","author":"GH Lo","year":"2000","unstructured":"Lo GH, Lai KH, Cheng JS, et al.: Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. Hepatology 2000, 32:461\u2013465.","journal-title":"Hepatology"}],"container-title":["Current Gastroenterology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-006-0058-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11894-006-0058-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11894-006-0058-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T14:10:45Z","timestamp":1707919845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11894-006-0058-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["58"],"URL":"https:\/\/doi.org\/10.1007\/s11894-006-0058-9","relation":{},"ISSN":["1522-8037","1534-312X"],"issn-type":[{"value":"1522-8037","type":"print"},{"value":"1534-312X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}